Publications by authors named "Vikrant Minhas"

Claim this Profile
C
Competence remodels the pneumococcal cell wall exposing key surface virulence factors that mediate increased host adherence.
Vikrant Minhas, Arnau Domenech, Dimitra Synefiaridou, Daniel Straume, Max Brendel

PLoS Biol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Nonadjuvanted Whole-Inactivated Pneumococcal Vaccine Induces Multiserotype Opsonophagocytic Responses Mediated by Noncapsule-Specific Antibodies.
Shannon C David, Erin B Brazel, Eve V Singleton, Vikrant Minhas, Zoe Laan

mBio· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sickly Sweet - How Sugar Utilization Impacts Pneumococcal Disease Progression.
Vikrant Minhas, James C Paton, Claudia Trappetti

Trends Microbiol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Site-Specific Mutations of GalR Affect Galactose Metabolism in Streptococcus pneumoniae.
Kimberley T McLean, Alexandra Tikhomirova, Erin B Brazel, Salomé Legendre, Gian Haasbroek, Vikrant Minhas

J Bacteriol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo dual RNA-seq reveals that neutrophil recruitment underlies differential tissue tropism of Streptococcus pneumoniae.
Vikrant Minhas, Rieza Aprianto, Lauren J McAllister, Hui Wang, Shannon C David

Commun Biol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host-glycan metabolism is regulated by a species-conserved two-component system in Streptococcus pneumoniae.
Patrick Rosendahl Andreassen, Claudia Trappetti, Vikrant Minhas, Flemming Damgaard Nielsen, Kevin Pakula

PLoS Pathog· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced safety and immunogenicity of a pneumococcal surface antigen A mutant whole-cell inactivated pneumococcal vaccine.
Shannon C David, Zoe Laan, Vikrant Minhas, Austen Y Chen, Justin Davies

Immunol Cell Biol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capacity To Utilize Raffinose Dictates Pneumococcal Disease Phenotype.
Vikrant Minhas, Richard M Harvey, Lauren J McAllister, Torsten Seemann, Anna E Syme

mBio· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis